Results 101 to 110 of about 36,179 (151)

Relapse following FLT3 inhibitor cessation in FLT3-ITD-positive AML: lessons from two clinical cases. [PDF]

Ann Hematol
Georgi JA, Röllig C, Schetelig J, Thiede C, Brückmann S, Bornhäuser M, Middeke JM.   +6 more
europepmc   +1 more source

CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial.

Blood
Laszig S, Diederichs A, Salzmann-Manrique E, Schuschel K, Gonçalves-Dias J, Issa H, Miladinovic M, Rettinger E, Wehner S, Kreyenberg H, Bremm M, Hünecke S, Kerp H, Waack-Buchholz K, Thol F, Goemans BF, De Moerloose B, Boztug H, Scheidegger N, Pawińska-Wąsikowska K, Reinhardt D, Klusmann JH.   +21 more
europepmc   +1 more source

The Combination Therapy With Sorafenib in Therapeutic Strategy of Acute Myeloid Leukemia. Is It Promising? A Narrative Review. [PDF]

Health Sci Rep
Shamahmood MN, Miri A, Mezginejad F.
europepmc   +1 more source

IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel. [PDF]

JACC CardioOncol
Kouwenberg TW, van Dalen EC, Mulder RL, Armenian S, Feijen EAM, Chow EJ, Kosmidis H, Vormoor-Bürger BJ, Kiyotani C, Nathan PC, Kapusta L, Grotenhuis HB, Engels FK, Teske AJ, Tragiannidis A, Slieker MG, Ozono S, Nohria A, Sláma T, Skinner R, Hudson MM, Kremer LCM, Ehrhardt MJ, Mavinkurve-Groothuis AMC.   +23 more
europepmc   +1 more source

Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort study. [PDF]

Lancet Reg Health Southeast Asia
Sidhu J, Chakraborty A, Das P, Steffen FD, Kundu S, Basu S, Tarafdar B, Dey T, Kar A, Biswas M, Das A, Sivadasan N, Dasgupta P, Ghara N, Bornhauser B, Bourquin JP, Krishnan S, Saha V.   +17 more
europepmc   +1 more source

Mixed-phenotype acute leukemia with trilineage differentiation presenting as a non-leukemic mediastinal tumor. [PDF]

J Clin Exp Hematop
Ichikawa S, Yamato M, Hatta S, Onodera K, Fukuhara N, Ichinohasama R, Harigae H.   +6 more
europepmc   +1 more source

CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis. [PDF]

Cardiooncology
Mitchell JD, Pfeiffer M, Boehmer J, Gorcsan J, Eguchi S, Orihara Y, Dronamraju N, Dhani S, Faderl S, Lin TL, Uy GL, Lancet JE, Cortes JE.   +12 more
europepmc   +1 more source

DNA Origami-Templated Aptamer Chiral Structures Realize Cellular Enantioselectivity. [PDF]

Adv Mater
Song T, Dwivedy A, Gandavadi D, Chandran G, An Y, Zheng M, Wang X, Zhou L, Zhao Y, Wang X.   +9 more
europepmc   +1 more source

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia. [PDF]

Hemasphere
Leonetti F, Kosanovic S, Rebollidos-Rios R, Manosalva I, Baier C, Yazir M, Constantinescu A, Souaid C, Pequerul R, Adamcova MK, Shaikh M, Havlová M, Costello R, Farrés J, Martin G, Alberich-Jorda M, Spicuglia S, Perez-Alea M.   +17 more
europepmc   +1 more source

A Bibliometric Analysis of Drug Resistance in Pediatric Acute Lymphoblastic Leukemia. [PDF]

Adv Biomed Res
Khanahmad A, Khazaee-Nasirabadi MH, Lotfi M, Hami A.   +3 more
europepmc   +1 more source